Table of Contents
Chapter 1. Global Biopharmaceutical Excipients Market Executive Summary
1.1. Global Biopharmaceutical Excipients Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Function
1.3.3. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Biopharmaceutical Excipients Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Biopharmaceutical Excipients Market Dynamics
3.1. Market Drivers
3.1.1. Rising demand for advanced drug formulations
3.1.2. Increasing investment in drug development
3.1.3. Technological advancements in extended-release formulations
3.2. Market Challenges
3.2.1. Compatibility issues with active pharmaceutical ingredients
3.2.2. High cost of development
3.2.3. Regulatory constraints
3.3. Market Opportunities
3.3.1. Development of biologics and biosimilars
3.3.2. Innovation in excipient technologies
3.3.3. Exploration of alternative routes of administration
Chapter 4. Global Biopharmaceutical Excipients Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Biopharmaceutical Excipients Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Biopharmaceutical Excipients Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Carbohydrates
5.2.2. Polyols
5.2.3. Solubilizers & Surfactants/Emulsifiers
5.2.4. Specialty Excipients
Chapter 6. Global Biopharmaceutical Excipients Market Size & Forecasts by Function 2022-2032
6.1. Segment Dashboard
6.2. Global Biopharmaceutical Excipients Market: Function Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Binders
6.2.2. Coatings
6.2.3. Disintegrants
6.2.4. Lubricants & Glidants
6.2.5. Pharmaceutical Fillers
6.2.6. Preservatives
Chapter 7. Global Biopharmaceutical Excipients Market Size & Forecasts by Application 2022-2032
7.1. Segment Dashboard
7.2. Global Biopharmaceutical Excipients Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Advanced Delivery Systems
7.2.2. Oral
7.2.3. Parenteral
7.2.4. Topical
Chapter 8. Global Biopharmaceutical Excipients Market Size & Forecasts by Region 2022-2032
8.1. North America Biopharmaceutical Excipients Market
8.1.1. U.S. Biopharmaceutical Excipients Market
8.1.1.1. Product breakdown size & forecasts, 2022-2032
8.1.1.2. Function breakdown size & forecasts, 2022-2032
8.1.1.3. Application breakdown size & forecasts, 2022-2032
8.1.2. Canada Biopharmaceutical Excipients Market
8.2. Europe Biopharmaceutical Excipients Market
8.2.1. U.K. Biopharmaceutical Excipients Market
8.2.2. Germany Biopharmaceutical Excipients Market
8.2.3. France Biopharmaceutical Excipients Market
8.2.4. Spain Biopharmaceutical Excipients Market
8.2.5. Italy Biopharmaceutical Excipients Market
8.2.6. Rest of Europe Biopharmaceutical Excipients Market
8.3. Asia-Pacific Biopharmaceutical Excipients Market
8.3.1. China Biopharmaceutical Excipients Market
8.3.2. India Biopharmaceutical Excipients Market
8.3.3. Japan Biopharmaceutical Excipients Market
8.3.4. Australia Biopharmaceutical Excipients Market
8.3.5. South Korea Biopharmaceutical Excipients Market
8.3.6. Rest of Asia Pacific Biopharmaceutical Excipients Market
8.4. Latin America Biopharmaceutical Excipients Market
8.4.1. Brazil Biopharmaceutical Excipients Market
8.4.2. Mexico Biopharmaceutical Excipients Market
8.4.3. Rest of Latin America Biopharmaceutical Excipients Market
8.5. Middle East & Africa Biopharmaceutical Excipients Market
8.5.1. Saudi Arabia Biopharmaceutical Excipients Market
8.5.2. South Africa Biopharmaceutical Excipients Market
8.5.3. Rest of Middle East & Africa Biopharmaceutical Excipients Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. BASF SE
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Ashland Global Holdings Inc.
9.3.3. Roquette Freres S.A.
9.3.4. Colorcon, Inc.
9.3.5. Croda International PLC
9.3.6. The Dow Chemical Company
9.3.7. Merck KGaA
9.3.8. Evonik Industries AG
9.3.9. SPI Pharma, Inc.
9.3.10. IMCD N.V.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes